The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran

Background and Aims. Nonalcoholic fatty liver disease (NAFLD) is common in severely obese individuals undergoing bariatric surgery. Assessing the prevalence and severity of NAFLD seems crucial since it may affect the prevention or development of more severe forms of fatty liver. Methods. This cross-...

Full description

Saved in:
Bibliographic Details
Main Authors: Ladan Aghakhani, Neda Haghighat, Masoud Amini, Seyed Vahid Hosseini, Seyed Jalil Masoumi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2022/5980390
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695978678910976
author Ladan Aghakhani
Neda Haghighat
Masoud Amini
Seyed Vahid Hosseini
Seyed Jalil Masoumi
author_facet Ladan Aghakhani
Neda Haghighat
Masoud Amini
Seyed Vahid Hosseini
Seyed Jalil Masoumi
author_sort Ladan Aghakhani
collection DOAJ
description Background and Aims. Nonalcoholic fatty liver disease (NAFLD) is common in severely obese individuals undergoing bariatric surgery. Assessing the prevalence and severity of NAFLD seems crucial since it may affect the prevention or development of more severe forms of fatty liver. Methods. This cross-sectional study was conducted on 228 severely obese individuals undergoing bariatric surgery. Abdominal ultrasonography was done, and clinical and biochemical factors (liver enzymes, lipid profile, and fasting blood sugar (FBS)) were assessed. Results. The mean body mass index (BMI) was 43.45±5.92 kg/m2. The prevalence of NAFLD was 49.12% (mild steatosis: 37.5%, moderate steatosis: 36.6%, and severe steatosis: 25.8%). The main risk factors of NAFLD were weight (p=0.002), BMI (p=0.003), alanine aminotransferase (ALT) (p<0.001), aspartate aminotransferase (AST) (p<0.001), serum triglycerides (TGs) (p=0.004), and FBS (p=0.039). The results revealed a statistically significant decrease in the mean level of high-density lipoprotein cholesterol (HDL-C) (p=0.044). However, no significant association was found between the severity of liver steatosis and the presence of comorbidities such as hypertension, diabetes, hypothyroidism, and dyslipidemia. Conclusions. More severe NAFLD was associated with increased weight and BMI. Elevated ALT, AST, TG, and FBS levels and decreased HDL-C levels were also the risk factors of NAFLD and its progress to more severe conditions.
format Article
id doaj-art-cd57d5ccbd884b6eab9d930b10a7daf6
institution DOAJ
issn 1687-630X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-cd57d5ccbd884b6eab9d930b10a7daf62025-08-20T03:19:35ZengWileyGastroenterology Research and Practice1687-630X2022-01-01202210.1155/2022/5980390The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in IranLadan Aghakhani0Neda Haghighat1Masoud Amini2Seyed Vahid Hosseini3Seyed Jalil Masoumi4Student Research CommitteeLaparoscopy Research CenterLaparoscopy Research CenterDepartment of SurgeryNutrition Research CenterBackground and Aims. Nonalcoholic fatty liver disease (NAFLD) is common in severely obese individuals undergoing bariatric surgery. Assessing the prevalence and severity of NAFLD seems crucial since it may affect the prevention or development of more severe forms of fatty liver. Methods. This cross-sectional study was conducted on 228 severely obese individuals undergoing bariatric surgery. Abdominal ultrasonography was done, and clinical and biochemical factors (liver enzymes, lipid profile, and fasting blood sugar (FBS)) were assessed. Results. The mean body mass index (BMI) was 43.45±5.92 kg/m2. The prevalence of NAFLD was 49.12% (mild steatosis: 37.5%, moderate steatosis: 36.6%, and severe steatosis: 25.8%). The main risk factors of NAFLD were weight (p=0.002), BMI (p=0.003), alanine aminotransferase (ALT) (p<0.001), aspartate aminotransferase (AST) (p<0.001), serum triglycerides (TGs) (p=0.004), and FBS (p=0.039). The results revealed a statistically significant decrease in the mean level of high-density lipoprotein cholesterol (HDL-C) (p=0.044). However, no significant association was found between the severity of liver steatosis and the presence of comorbidities such as hypertension, diabetes, hypothyroidism, and dyslipidemia. Conclusions. More severe NAFLD was associated with increased weight and BMI. Elevated ALT, AST, TG, and FBS levels and decreased HDL-C levels were also the risk factors of NAFLD and its progress to more severe conditions.http://dx.doi.org/10.1155/2022/5980390
spellingShingle Ladan Aghakhani
Neda Haghighat
Masoud Amini
Seyed Vahid Hosseini
Seyed Jalil Masoumi
The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran
Gastroenterology Research and Practice
title The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran
title_full The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran
title_fullStr The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran
title_full_unstemmed The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran
title_short The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran
title_sort risk factors of nonalcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery in iran
url http://dx.doi.org/10.1155/2022/5980390
work_keys_str_mv AT ladanaghakhani theriskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT nedahaghighat theriskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT masoudamini theriskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT seyedvahidhosseini theriskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT seyedjalilmasoumi theriskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT ladanaghakhani riskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT nedahaghighat riskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT masoudamini riskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT seyedvahidhosseini riskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran
AT seyedjalilmasoumi riskfactorsofnonalcoholicfattyliverdiseaseinmorbidlyobesepatientsundergoingbariatricsurgeryiniran